CTLA4 and medulloblastoma: The immune checkpoint analysis of the 19 genes in our series of 80 medulloblastomas showed overall low mRNA levels, particularly of the canonic actionable targets PDCD1 (PD-1), CD274 (PD-L1), and CTLA4 (Figure 1).